ESR1 and breast carcinoma: In cells devoid of estrogen receptors, it is likely that restoration of ERα cannot enable a stimulation of proliferation upon E2 treatment, since it triggers a different program of transcriptional regulation, compared to cells expressing naturally ERα, as previously showed in breast cancer cells [37].